Role of flavonoids on oxidative stress and mineral contents in the retinoic acid-induced bone loss model of rat
- 659 Downloads
Reactive oxygen species play a role in a number of degenerative conditions including osteoporosis. Flavonoids as phyto-oestrogens exert physiological effects against oxidative stress diseases. We developed a retinoic acid-induced bone loss model of rats to assess whether flavonoids and alendronate as positive control have role against oxidative stress and mineral contents in osteoporosis in vivo.
Three-month-old female rats of the Y59 strain were given quercetin, chrysin, naringenin (100 mg kg−1) or alendronate (40 mg kg−1, a positive control) immediately before retinoic acid treatment (80 mg kg−1) once daily for 14 days by a single intragastric (i.g.) application. In the second part of the study, we assessed the effect of those flavonoids on the skeletal system of healthy rats using single i.g. application on the respective flavonoids during 14 days. Twenty-four hours after the treatment, we analysed bone mineral density and the total content of bone calcium and phosphorus in the femur, the geometric and physical characteristics of thigh bones and lipid peroxidation and glutathione levels of liver and kidney cells.
All flavonoids improved the decrease in bone weight coefficient, the length and the diameter of the bone, the content of bone ash and calcium and phosphorus content induced by retinoic acid. Chrysin and quercetin showed promise as preventive agents. Flavonoids were superior to alendronate according to some criteria.
These results suggest that the dietary flavonoids could reduce retinoic acid-induced oxidative stress and bone loss and that flavonoids may be useful therapeutics for prevention of skeletal diseases.
KeywordsFlavonoids Retinoic acid Bone loss prevention Oxidative stress Rat
This work was supported by the Ministry of Sciences, Education and Sports of the Republic of Croatia Project No. 119-0000000-1255.
Conflict of interest
There are no conflicts of interest to declare.
- 1.Oršolić N, Bašić I (2008) Honey bee products and their polyphenolic compounds in treatment of diabetes. Phytopharmacology and therapetic values IV, vol 22. In: Govil JN, Singh VK (eds) Recent progress in medicinal plants. Studium Press, LLC, USA, pp 455–553Google Scholar
- 5.Nieves JW (2012) Skeletal effects of nutrients and nutraceuticals, beyond calcium and vitamin D. Osteoporos Int 24:771–786Google Scholar
- 9.Bitto A, Burnett BP, Polito F, Levy RM, Marini H, Di Stefano V, Irrera N, Armbruster MA, Minutoli L, Altavilla D, Squadrito F (2009) Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate. Br J Pharmacol 156:1287–1295CrossRefGoogle Scholar
- 10.Fahmy SR, Soliman AM (2009) Oxidative stress as a risk factor of osteoporotic model induced by vitamin A in rats. Aust J Basic Appl Sci 3:1559–1568Google Scholar
- 15.Peng X, Jianfeng Y, Weizhang J, Qiankun C, Xio G (2005) The effect of osteoporotic model rats induced by retinoic acid. Chin Int J Traumatol 4:1–6Google Scholar
- 16.Goldenberg F, Fernandez A (1966) Simplified method for the estimation of inorganic phosphorus in body fluids. Clin Chem 12:871–872Google Scholar
- 17.Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275Google Scholar
- 21.Hotchkiss CE, Latendresse J, Ferguson SA (2006) Oral treatment with retinoic acid decreases bone mass in rats. Comp Med 56:502–511Google Scholar
- 23.Evans DB, Bunning RA, Russell RG (1990) The effects of recombinant human interleukin-1 beta2 on cellular proliferation and the production of prostaglandin E, plasminogen activator, osteocalcin and alkaline phosphatase by osteoblast-like cells derived from human bone. Biochem Biophys Res Commun 166:208–216CrossRefGoogle Scholar
- 25.Prouillet C, Mazière JC, Mazière C, Wattel A, Brazier M, Kamel S (2004) Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol 67:1307–1313CrossRefGoogle Scholar
- 26.Xu YX, Wu CL, Wu Y, Tong PJ, Jin HT, Yu NZ, Xiao LW (2012) Epimedium-derived flavonoids modulate the balance between osteogenic differentiation and adipogenic differentiation in bone marrow stromal cells of ovariectomized rats via Wnt/β-catenin signal pathway activation. Chin J Integr Med 18:909–917CrossRefGoogle Scholar
- 36.Sirovina D, Orsolic N, Končić Zovko M, Kovačević G, Benković V, Gregorović G (2013) Quercetin vs Chrysin: Effect on liver histopathology in diabetic mice. Human and Exp Toxicol 32:1058–1066Google Scholar
- 38.Moskaug JØ, Carlsen H, Myhrstad MC, Blomhoff R (2005) Polyphenols and glutathione synthesis regulation. Am J Clin Nutr 81:277S–283SGoogle Scholar